BN Business News
Add your company to Business Communicator →

Market regulation · 26/05/2004Updated: 10/17/2026 · 1 min read

Bentley Pharmaceuticals, Inc. Seeks to Delist Its Common Stock from the American Stock Exchange LLC

Summary

Bentley Pharmaceuticals, Inc. has submitted a notice to withdraw its common stock, par value $.02, from listing and registration on the American Stock Exchange LLC, as indicated by file number 1-10581.

Original source language: Federal Register — SECOpen original release →

Explore insights

Business insights →